gradiant bioconvergence
Biotechnology Research • 
송파구 정의로7길 6, PNS홈즈타워 4층, Korea, Republic of • 11-20 Employees
Company overview
| Headquarters | 송파구 정의로7길 6, PNS홈즈타워 4층, Seoul, KR |
| Website | |
| Employees | 11-20 |
Key Contact at gradiant bioconvergence
Jinguen Rheey
Chief Executive Officer
gradiant bioconvergence Email Formats
gradiant bioconvergence uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@gradiantbio.com), used 40% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@gradiantbio.com | 40% |
{first name}.{last name} | john.doe@gradiantbio.com | 40% |
{first initial}{last name} | jdoe@gradiantbio.com | 20% |
About gradiant bioconvergence
Gradiant Bioconvergence (GBCC) is a pioneer in the development of patient-derived cancer organoids (PDOs) on a global scale. We have established Asia’s largest PDO repository, comprising over 800 models from patients with lung, gastric, colorectal, pancreatic, and ovarian cancers, all characterized using next-generation sequencing. In parallel, we are advancing co-culture systems that integrate autologous immune cells and cancer-associated fibroblasts with our PDOs. Leveraging our comprehensive genomic, transcriptomic and drug response datasets, we are identifying and validating novel drug-resistant oncology targets through our AI-driven discovery engine and CRISPR-enabled PDO platform. Beyond oncology, GBCC is also developing brain organoids from human iPSCs to support drug evaluation, disease modeling and regenerative medicine applications.
gradiant bioconvergence revenue & valuation
| Annual revenue | $941,105 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
gradiant bioconvergence has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
gradiant bioconvergence has never raised funding before.
gradiant bioconvergence Tech Stack
Discover the technologies and tools that power gradiant bioconvergence's digital infrastructure, from frameworks to analytics platforms.
SSL/TLS certificate authorities
Reverse proxies
United States
Australia
Egypt
SpainFrequently asked questions
4.8
40,000 users
